UNICA IRIS Institutional Research Information System

FULGHESU, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 73.183
NA - Nord America 4.979
AS - Asia 564
OC - Oceania 24
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 78.766
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 71.602
US - Stati Uniti d'America 4.961
UA - Ucraina 555
CN - Cina 454
SE - Svezia 414
GB - Regno Unito 162
FI - Finlandia 142
DE - Germania 141
IE - Irlanda 53
SG - Singapore 49
FR - Francia 45
RU - Federazione Russa 29
AU - Australia 22
IN - India 21
CA - Canada 16
PK - Pakistan 13
BE - Belgio 12
NL - Olanda 8
EU - Europa 7
IR - Iran 5
LT - Lituania 5
EG - Egitto 4
ID - Indonesia 4
RO - Romania 4
VN - Vietnam 4
ES - Italia 3
NG - Nigeria 3
CH - Svizzera 2
HK - Hong Kong 2
LY - Libia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
DK - Danimarca 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
PA - Panama 1
SY - Repubblica araba siriana 1
Totale 78.766
Salva come PNG Salva come JPEG
Città #
Cagliari 71.256
Fairfield 672
Woodbridge 482
Chandler 433
Houston 410
Ashburn 373
Wilmington 303
Nyköping 297
Jacksonville 293
Ann Arbor 287
Seattle 278
Cambridge 245
Boardman 146
Nanjing 127
Boston 104
Dearborn 104
Menlo Park 104
Helsinki 75
Beijing 57
San Diego 44
Redwood City 36
Hebei 33
Shenyang 33
Milan 32
Shanghai 29
Nanchang 27
Changsha 26
Jiaxing 25
Orange 24
Tianjin 19
Norwalk 16
Verona 14
Los Angeles 13
Toronto 13
Brussels 12
Guangzhou 12
Pune 11
Jinan 10
Washington 10
Rome 9
Saint Petersburg 9
Zhengzhou 9
Kunming 8
New York 8
Sassari 8
Hefei 7
London 7
Mountain View 6
Auburn Hills 5
Bologna 5
Dublin 5
Gonnosfanadiga 5
Kilburn 5
Redmond 5
Siauliai 5
Taizhou 5
Alghero 4
Dong Ket 4
Hunawihr 4
Tehran 4
Assèmini 3
Brisbane 3
Chicago 3
Falls Church 3
Frankfurt am Main 3
Hangzhou 3
Morwell 3
Napoli 3
Olbia 3
San Mateo 3
Sanluri 3
Singapore 3
Stockholm 3
Tappahannock 3
Wuhan 3
Acton 2
Amsterdam 2
Ancona 2
Barcelona 2
Cassibile 2
Cedar Knolls 2
Chengdu 2
Chiswick 2
Dolianova 2
Fagagna 2
Fishers 2
Florence 2
Huzhou 2
Jakarta 2
Kumar 2
Lahore 2
Melbourne 2
Millbury 2
Montalto Uffugo 2
New Bedfont 2
Ningbo 2
Palermo 2
Parma 2
Phoenix 2
Quartu Sant'elena 2
Totale 76.707
Salva come PNG Salva come JPEG
Nome #
IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance 2.611
Is there a dose-response relationship of metformin treatment in patients with polycistic ovary syndrome? Results from a multicentric study 2.348
Il-6 serum levels and production in PCOS adolescents is related to insulin resistance 2.092
The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population 2.079
Inflammatory response to lypopolysaccharide in mononuclear cells from polycystic ovary syndrome insulin resistant adolescent 2.059
Very low dose of flutamide in the treatment of hyperandrogenism 2.013
Stained amniotic fluid: what's new? 1.975
Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome 1.759
The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome 1.550
Ultrasound diagnosis of polycystic ovarian syndrome: current guidelines, criticism and possible update 1.544
Obesity related lipid profileand altered insulin incretion in adolescent with policystic ovary syndrome 1.452
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. 1.437
L'ovaio nella Sindrome dell'ovaio policistico 1.416
Ovulation induction in young girls with menometrorragia: a safe and effective treatment 1.394
Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome 1.379
Pathogenesis 1.192
INDICAZIONE AL PARTO CESAREO PRESSO LA CLINICA OSTETRICA E GINECOLOGICA DI CAGLIARI: SU QUALI POSSIAMO RIDURRE IL RICORSO AL PARTO CESAREO? 1.147
Dismenorrea: dalle limitazioni alla quotidianità ai dolori pelvici 1.122
null 1.083
ANALGESIA EPIDURALE E INCIDENZA DI TAGLIO CESAREO. 1.062
Ecografia in ginecologia dell'infanzia e dell'adolescenza. Testo atlante 1.022
Obesity realated lipid profile and altered insulin incretion in adolescent with PCOS 1.021
Diagnosis of metabolic disorders in women with polycystic ovary syndrome 987
Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome 973
Metformin effect on ovarian ultrasoundappearance and steroidogenetic functionin normal weightnormoinsulinemic women with polycystic ovary sindrome:a randomized double blind placebo-controlledclinical trial 921
78) PITUITARY – OVARIAN RESPONSE TO GONADOTROPIN- RELESING HORMONE AGONIST TEST IN ANOVULATORY PATIENTS WITH POLYCYSTIC OVARY STROMA. PREDICTIVE ROLE OF OVARIAN STROMA 840
133. Metformin effect in PCOS patients is not dose dependent 806
Differenze regionali nella risposta alla Metformina in pazienti con PCOS 805
Endocrine and metabolic aspects in obese and lean young PCOS 764
Criteri diagnostici di PCOS: recenti evoluzioni 754
null 740
null 735
The quantitative insulin sensitivity check index (QUICKY) is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome 734
Good practice in pediatric and adolescent gynecology 727
Diagnosi dei problemi metabolici nelle donne con PCOS 720
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 713
Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS) 713
Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. 704
Ultrasound in PCOS: revisiting Rotterdam criteria 694
Influenza dei parametri antropometrici sulla risposta alla Metformina in pazienti con PCOS. 684
LA DIAGNOSI ECOGRAFICA DELLA PCOS 680
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study. 673
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease. 668
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome. 663
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome. Dexamethasone and GnRH-agonist administration. 654
Opioid blockade effect on insulin beta-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus 637
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion. 632
Ovarian stroma in PCOS: relationship with circulating androgens 630
CHANGES IN LUTEINIZING HORMONE AND INSULIN SECRETION IN POLYCYSTIC OVARIAN SYNDROME 615
Ovarian stromal hypertropy and insulin abnormalities in PCOS 608
Iperinsulinemia in adolescenti affette da PCOS 603
null 565
Confronto tra autovalutazione e valutazione clinica dell’irsutismo e dell’immagine corporea in adolescenza 564
82. Pituitary-ovarian response to gonadotrpin-releasing hormone-agonist test in anovulatory patients with polycystic ovary sindrome. Predictive role of ovarian stroma 562
Assetto lipidico in adolescenti affette da PCOS 557
Espressione genica e livelli circolanti di resistita in giovani pazienti affette da PCOS 556
EFFECT OF OPIOID BLOCKADE ON INSULIN AD GROWTH HORMONE (GH) SECRETION IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME: THE HETEROGENEITY OF IMPAIRED GH SECRETION IS RELATED TO BOTH OBESITY AND HYPERINSULINISM 538
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL-AXIS RESPONSE TO NALOXONE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME 533
PRECONCEPTIONAL AND GESTATIONAL EVALUATION OF INSULIN SECRETION IN PATIENTS WITH COLYCYSTIC OVARY SYNDROME 528
Ovarian stromal hypertrophy and insulin abnormalities in young PCOS 520
N-ACETYL-CYSTEINE TREATMENT IMPROVES THE INSULIN SENSITIVITY IN PCOS 513
Relationship between genetic and metabolic abnormalities in PCOS 491
THE IMPACT OF INSULIN SECRETION ON THE OVARIAN RESPONSE TO EXOGENOUS GONADOTROPINS IN POLYCYSTIC OVARY SYNDROME 490
ACUTE INSULIN RESPONSE TO INTRAVENOUS GLUCAGONE IN POLYCYSTIC OVARY SYNDROME 469
EVIDENCE OF A DISTINCT DERANGEMENT OF OPIOID TONE IN HYPERINSULINEMIC PATIENTS WITH POLYCYSTIC OVARY SYNDROME: RELATIONSHIP WITH INSULIN AND LUTEINIZING HORMONE 448
CORTICOTROPIN RELEASING HORMONE INDUCES AN EXAGGERATED RESPONSE OF ADRENOCORTICOTROPIC HORMONE AND CORTISOL IN POLYCYSTIC OVARY SYNDROME 445
ENDOCRINO-METABOLIC FEATURES IN WOMEN WITH POLYCYSTIC OVARY SYNDROME DURING PREGNANCY 417
EFFECT OF OPIOID BLOCKADE ON INSULIN METABOLISM IN POLYCYSYIC OVARIAN DISEASE 412
SOMATOSTATIN TREATMENT REDUCES THE EXAGGERATED RESPONSE OF ADRENOCORTICOTROPIN HORMONE AND CORTISOL TO CORTICOTROPIN -RELEASING HORMONE IN POLYCYSTIC OVARY SYNDROME 402
null 395
An open multicenter study to compare the efficacy of intraperitoneal insemination and intrauterine insemination following multiple follicular development as treatment for unexplained infertility 369
EFFECTIVENESS OF A SOMATOSTATIN ANALOGUE IN LOWERING LH AND INSULIN SECRETION IN HYPERINSULINEMIC WOMEN WITH POLYCYSTIC OVARIAN DISEASE 355
TEMPOROLIMBIC EPILEPSY AND POLYCYSTIC OVARY SYNDROME 348
Knowledge of the microbiota: personal experience from 324 questionnaires administered to mother and mothers-to-be. 344
Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome 325
GROWTH HORMONE ENHANCES ESTRADIOL PRODUCTION FSH INDUCED IN THE EARLY STAGE OF THE FOLLICULAR MATURATION 322
La clinica dei disturbi mestruali in adolescenza: risultati di un’analisi sul territorio 320
Which treatment options should be used in adolescents with polycystic ovary syndrome? 311
EVIDENCE OF A DISTURBANCE OF THE HYPOTALAMIC PITUITARY ADRENAL AXIS IN POLYCYSTIC OVARY SYNDROME EFFECT OF NALOXONE 309
Correlation of ovarian stromal hypertrophy to hyperandrogenism and insulin resistance in young women with PCOS 304
Adolescence and hyperinsulinemia: it is always the first step towards PCOS? 303
La clinica dei disturbi mestruali in adolescenza: risultati di un’analisi sul territorio 300
Hirsutism and hyperandrogenism associated with hyperreactio luteinalis in a singleton pregnancy: a case report. 299
The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside. A Systematic Literature Review 290
Ultrasound in polycystic ovary syndrome--the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study 289
Prevalenza dei markers di autoimmunità nelle pazienti affette da preeclampsia 288
HETEROGENEITY IN ß- CELL ACTIVITY, HEPATIC INSULIN CLEARANCE AND PERIPHERAL INSULIN SENSITIVITY IN WOMEN WITH POLYCYCSTIC OVARY SYNDROME 282
Studio osservazionale sulle irregolarità mestruali in adolescenza 271
Influenza del peso sulla risposta al test all’analogo del GnRH (GnRHa) in PCOS 269
Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease. 263
Insulin and GH secretion in adolescent girls with irregular cycles: polycystic vs multifollicular ovaries 258
Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist. 249
Effect of maternal carbohydrate metabolism on fetal growth. 241
Serum CA-125 levels do not depend on ovarian steroidogenesis 240
Luteal responses to gonadotropin-releasing hormone during the luteal phase: relation to the age of corpus luteum. 231
Progesterone and LH variations after LH-RH administration in the luteal phase of the menstrual cycle. 231
Continuous subcutaneous insulin infusion (CSII) in pregnant diabetic women 227
Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease. 226
LH surge induction by GnRH agonist at the time of ovulation. 226
Polycystic Ovarian Morphology in Normocyclic Non-hyperandrogenic Adolescents 226
Totale 73.755
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.320
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019690 0 0 0 0 0 0 0 0 0 0 364 326
2019/202017.734 920 476 123 380 6.861 4.083 2.515 524 493 384 371 604
2020/202120.161 875 694 852 5.016 4.777 2.334 2.079 1.280 320 745 736 453
2021/20225.423 614 410 311 304 515 287 509 400 308 505 610 650
2022/20239.880 708 1.033 1.217 923 568 769 462 914 817 819 1.217 433
2023/202410.653 404 338 372 574 1.147 2.068 2.134 633 1.185 884 914 0
Totale 79.087